ADAM23 and astrocytoma (excluding glioblastoma): To evaluate ADAM23 expression in CNS tumors, we measured ADAM23 mRNA levels using qRT-PCR in the non-neoplastic brain (NNB) and 143 WHO Grades 2–4 astrocytomas from the HC cohort.